IP Library Assignment 018001/0835
Patent Assignment
Reel/Frame 018001/0835

Assignment of Assignor's Interest

Recorded: 2006-06-15 Pages: 2
Assignors
ONICHTCHOUK, DARIA
Executed: 2006-02-20
BURK, ULRIKE
Executed: 2006-02-13
Assignee
DEVELOGEN AKTIENGESELLSCHAFT
MARIE-CURIE-STR. 7, GOETTINGEN, 37079, GERMANY
Covered Property (1)
Use of Pleitrophin for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
Patent: 8,501,473 →
Application: 10/564,769 →
Publication: US 2010/0162421
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2006
From: ONICHTCHOUK, DARIA
To: DEVELOGEN AKITIENGESELLSCHAFT
Reel/Frame 017467/0177 →
Change of Name Jan 16, 2013
From: DEVELOGEN AKTIENGESELLSCHAFT
To: EVOTEC (GOTTINGEN) AG
Reel/Frame 029636/0032 →
Change of Name Jan 17, 2013
From: EVOTEC (GOTTINGEN) AG
To: EVOTEC NEUROSCIENCES GMBH
Reel/Frame 029646/0503 →
Change of Name Jan 18, 2013
From: EVOTECH NEUROSCIENCES GMBH
To: EVOTECH INTERNATIONAL GMBH
Reel/Frame 029660/0805 →
Corrective Assignment to Correct the Evotech Neurosciences Gmbh, Assignor and Evotech International Gmbh, Assignee Names Previously Recorded on Reel 029660 Frame 0805. Assignor(S) Hereby Confirms the Evotec Neurosciences Gmbh, Assignor and Evotec International Gmbh, Assignee. Jan 29, 2013
From: EVOTEC NEUROSCIENCES GMBH
To: EVOTEC INTERNATIONAL GMBH
Reel/Frame 029711/0363 →